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Abstract
Background: Inflammatory respiratory diseases are amongst major global health challenges. Lung fibroblasts have
been shown to play a key role in lung inflammatory responses. However, their exact role in initiation and maintenance
of lung diseases has remained elusive partly due to the limited availability of physiologically relevant in vitro models.
Therefore, developing new tools that enable investigating the molecular pathways (e.g. nuclear factor-kappa B (NF-κB)
activation) that underpin inflammatory responses in fibroblasts could be a valuable resource for scientists working in
this area of research.
Results: In order to investigate NF-κB activation in response to pro-inflammatory stimuli in real-time, we first developed
two detection systems based on nuclear localization of NF-κB by immunostaining and luciferase reporter assay system.
Furthermore using electrospun porous scaffolds, with similar geometry to human lung extracellular matrix, we developed
3D cultures of lung fibroblasts allowing comparing NF-κB activation in response to pro-inflammatory stimuli (i.e. TNF-α) in
2D and 3D. Our data clearly show that the magnitude of NF-κB activation in 2D cultures is substantially higher than 3D
cultures. However, unlike 2D cultures, cells in the 3D model remained responsive to TNF-α at higher concentrations. The
more subdued and wider dynamic range of NF-κB responses in 3D culture system was associated with a different
expression pattern for TNF receptor I in 3D versus 2D cultures collectively reflecting a more in vivo like TNF receptor I
expression and NF-κB activation pattern in the 3D system.
Conclusion: Our data suggest that lung fibroblasts are actively involved in the pathogenesis of lung inflammation
by activation of NF-κB signaling pathway. The 3D culture detection system provides a sensitive and biologically
relevant tool for investigating different pro-inflammatory events involving lung fibroblasts.
Keywords: Nuclear factor Kappa B, NF-κB, Tumor Necrosis Factor-α, TNF-α, Lung fibroblasts, Lung inflammation,
3D cell culture, Electrospinning
Background
Inflammation is thought to be the central mechanism
for many chronic lung disorders such as asthma, chronic
obstructive pulmonary disease, and idiopathic lung fibrosis
although the specific features and anatomical sites affected
in each disease are different. Immune cells recruited at the
site of inflammation are regarded as the key effector cells
in lung inflammation through the production of various
proinflammatory cytokines [1]. However, once inflamma-
tion is triggered, a chronic inflammatory response persists
following lung injury. It is now accepted that in addition
to immune cells, the structural lung cells such as airway
epithelium, smooth muscles and lung fibroblasts also play
an important role in initiation and maintenance of chronic
lung inflammation through producing proinflammatory
cytokines and growth factors [2–5].
Fibroblasts have been shown to produce a plethora of in-
flammatory mediators such as Interleukin-8 (IL-8), mono-
cyte chemoattractant protein (MCP-1,3,4), macrophage
inflammatory protein-1-alpha (MIP-1-α), eotaxin, granulo-
cyte monocyte colony stimulating factor (GM-CSF), platelet
derived growth factor (PDGF) and transforming growth
factor-beta (TGF)-β during the acute and chronic phase of
lung inflammation[6–9]. At the transcriptional level, the ex-
pression of genes controlling these inflammatory cytokines
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are under the control of nuclear factor kappa B (NF-κB),
which plays a central role in regulating the expression of
many genes involved in inflammation [10]. Fibroblasts can
also proliferate and have the potential to transform into
myofibroblasts [11, 12]. This could be in response to the cy-
tokines produced by other cells (e.g. epithelial cell or mono-
cytes) or through direct response to injury or exogenous
stimuli [13, 14].
The ability to study the molecular pathways control-
ling the inflammatory responses in fibroblasts, such as
those involved in NF-κB activation under in vivo like
conditions will no doubt provide a better insight and un-
derstanding of lung inflammation, particularly in lung fi-
brosis where fibroblasts play a central role in pathogenesis.
In addition to being a transcription factor controlling a
number of inflammatory responses, NF-κB activation is
probably the earliest cellular event in response to exogen-
ous stress and injury [15]. Moreover, NF-κB has been
shown to be activated in structural cells of lung in associ-
ation with increased transcription of some proinflamma-
tory cytokines and growth factors [16–18]. Thus, detection
of NF-κB activation can not only act as a sensitive probe
for inflammatory responses in human lung but also pro-
vide a useful tool for monitoring the impact of drug inter-
vention or progression of chronic lung inflammation.
In unstimulated cells, NF-κB is bound to an inhibitor
(IκB) in the cytoplasm preventing it from entering the
nuclei. Upon exposure to external stimuli, IκB is
promptly phosphorylated, ubiquitinated and degraded by
26S proteasomes releasing active NF-κB into the nucleus
[19] in which it binds to a specific sequence in the pro-
moter regions of target inflammatory genes leading to
the activation of RNA polymerase type-II and synthesis
of mRNA. Two cytokines, TNF-α and IL-1β, produced
by inflammatory cells especially monocyte/macrophages
in the early inflammatory stage, are also shown to be
capable of setting up a positive feedback loop in NF-κB
activation pathway which is important for perpetuation
of a local inflammatory response [10]. Moreover these
two cytokines have been shown to be involved in initial
activation of fibroblasts for synthesis of inflammatory
mediators [4, 7, 9, 20–22]. More importantly TNF-α it-
self has been demonstrated to play a central role in
pathology of various pulmonary diseases [23].
Most studies on NF-κB activation have been per-
formed in conventional 2D culture systems, however the
limitations of 2D cell cultures are becoming more
apparent [24, 25]. For example, in vivo fibroblasts are
non-polar cells supported by ECM and exist in a 3D
conformation within a particular geometry. The polarity,
morphology and migratory properties of fibroblasts cul-
tured in vitro on 2D surface becomes distorted in order to
adapt the commonly used flat rigid artificial surface of tis-
sue culture flasks/plates [26]. Human fibroblasts seeded in
cell derived tissue matrix have higher proliferation than
when cultured in 2D [27]. Moreover, it was shown that
fibroblasts have greater cell attachment when cultured on
3D scaffolds, as they provide an environment for spatial
organization, sustainment and high density culturing
[27–31]. Furthermore, cells cultured in 3D rather than 2D
are thought to be able to withstand more stress when en-
countered cytotoxic agents [24]. Thus, it is reasonable to
assume that studying the fibroblast response to different
stimuli leading to NF-κB activation in 3D better reflects
the functional properties of these cells in vivo.
We have recently reported development of nano- and
micro-diameter electrospun scaffolds from poly (ethylene
terephthalate) (PET) capable of supporting the 3D growth
and differentiation of lung epithelial cells and fibroblasts
for up to 4 weeks [32, 33]. Interestingly, we and others
have shown that such electrospun scaffolds with fibre di-
ameters of approximately 240 ± 70 nm highly resemble the
natural ECM of normal lung tissue (245 ± 83 nm) [33, 34].
Using such biomimetic electrospun scaffolds, in this
study we investigated NF-κB signaling in lung fibroblasts
under inflammatory conditions using immunostaining and
luciferase reporter assay that enable non-invasive monitor-




Recombinant human TNF-α was purchased from Gibco
(Life Technologies, UK) and Ready-To-GlowTM NF-κB
secreted luciferase reporter system (Cat No-631743) was
obtained from Clontech laboratories (Palo Alto, CA).
The Lipofectamine® 2000 (1 mg/mL) for transfection
and Alamar Blue cell viability assay were obtained from
Invitrogen (life technologies, UK). Fetal calf serum (FCS)
was purchased from Labtech (UK) and Eagle’s minimal
essential medium (MEM), L-Glutamine (200 mM),
penicillin-streptomycin (10000 IU/mL/100 mg/mL) and
trypsin-EDTA (10x) were from Sigma-Aldrich (UK). Pri-
mary anti-NF-κB/p65 (C-20) rabbit polyclonal IgG anti-
body was from Santa Cruz Biotechnology (sc-109, CA,
USA), TNF receptor I rabbit polyclonal IgG antibody
was from Abcam (19139) and Alexa Fluor® 488 goat
anti-rabbit IgG secondary antibody (H + L) was from
Molecular Probes (Life Technologies, UK).
Polyethylene terephthalate (PET) scaffold fabrication
10 % Electrospun Polyethylene terephthalate (PET) was
fabricated using published method described in Harrington
et al [33]. Briefly, PET was dissolved in 1:1 trifluoroacetic
acid (TFA): dichloromethane (DCM) (Fisher Chemicals,
U.K.) to create a 10 % (w/v) solution. The polymer solution
was loaded into a syringe (10 mL) with an 18 gauge needle
(BD Falcon, U.K). The syringe was securely assembled on a
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syringe pump driver (Harvard Apparatus Ltd., U.K.). A
grounded steel collector plate was positioned 15 cm dis-
tance from the needle tip. Then PET polymer solution was
pumped at a constant flow rate of 0.5 mL/h at 14 kV for
4 h. Scaffold sheets were placed in a fume hood for 24 h to
air dry. In order to have unique characteristics of scaffold
such as thickness, diameter of fibres and pore sizes at each
electrospinning, experimental conditions described in
Table 1 were specified for each electrospinning. The pore
size of the scaffold was determined using the SEM image
analysis. According to Morris et al. [32], the pore size was
defined by the longest distance within the defined pore on
the same focal plane [32].
Scanning electron microscopy
PET electrospun scaffolds were analysed by SEM (Scan-
ning Electron Microscopy) (JEOL JMS-6060 LV micro-
scope, U.K.) by mounting PET scaffold on carbon-coated
electron microscope stubs and gold sputter coating for
4 min under an argon atmosphere (Blazers Union, SCD
030, BOC, U.K.) prior to analysis.
Culture conditions and 2D cell culture
The human fetal lung fibroblast cell line (MRC-5) was ob-
tained from the American Type Culture Collection (ATCC)
and routinely cultured in T75 flasks in Eagle’s minimal es-
sential medium (MEM) supplemented with 2 mM L-
Glutamine, 10 % FCS and penicillin-streptomycin (100 IU/
mL / 100 μg/mL) at 37 °C, 5 % CO2 in a humidified incu-
bator until confluent. The culture medium was changed
three times a week. When confluent, the cells were trypsi-
nized with 1x trypsin-EDTA, centrifuged at 350 g for 5 min
at room temperature, seeded directly into a 24 well plate
(Costar) in transfection experiment and HCL treated cover-
slip was used for cell seeding in immunostaining. 1.5 ×105
cells in 500 μL per well was used for all experiments. Then
the cells were incubated in a humidified incubator for 24 h
to allow cell adherence before transfection. Passage num-
bers 10–20 were used.
3D cell culture on PET scaffolds
Scaffold sheets were cut and sterilized under UV light
(254 nm), 15 min on each side and then incubated with
70 % ethanol for 20 min in a non-tissue culture treated 12
well plates. Sterilized stainless steel rings (inner diameter -
1 cm, outer diameter - 1.9 cm and height - 0.8 cm) were
used to hold down the scaffold and limit cell attachment
in the centre of scaffold. After placing steel rings on the
top of the PET scaffold, it was then sterilized with an
antibiotic/antimycotic solution (5 %) (A5955, Sigma) over-
night. Before cell seeding, PET scaffolds were washed with
PBS x 2 times then soaked in complete MEM culture
medium for 1 h. A cell suspension 1.5 × 105 cells in
500 μL of complete MEM medium was seeded on the
PET scaffold inside the steel ring while placing the same
amount of medium outside. After seeding, the plate was
incubated for 24 h to allow cell adherence to the scaffold
before transfection.
Immunostaining of NF-κB /p65 subunit and TNF receptor
I expression (2D and 3D culture)
Briefly, the same culture condition for both 2D (cover-
slip) and 3D (PET scaffold) cultures was used for immu-
nostaining of NF-κB and TNF-α receptor I expression.
NF-κB activation was determined in MRC5 lung fibro-
blasts by immunostaining for the intracellular position
of p65, the transcriptionally active subunit of NF-κB, as
previously described [35]. Samples were fixed using 4 %
(w/v) paraformaldehyde for 20 min at room temperature
after 1 hr stimulation with TNF-α (2 ng/ml). TNF-α re-
ceptor I expression was studied without TNF-α stimula-
tion and permeabilisation. Cells were permeabilized with
0.2 % (v/v) Triton for 20 min at room temperature and
neutralized with 50 mM ammonium chloride for 5 min.
Cells were washed three times in PBS after each treatment.
Unreactive binding sites were blocked with 5 % (w/v) bo-
vine serum albumin (Sigma) in PBS for 30 min. Cells were
then incubated with primary anti-NF-κB/p65, anti TNF re-
ceptor I antibody for 1 h at room temperature (1:100 (v/v)
in PBS). Cells were washed with PBS 3 times then incu-
bated with Alexa Fluor® 488 goat anti-rabbit IgG secondary
antibody (H+ L) (1:1000 v/v in PBS) for 1 h at room
temperature in the dark, washed 3x with PBS, followed by
incubation with 300 nM DAPI (Sigma-Aldrich) in the dark
for 30 min. Images were captured using 40x objectives of
Zeiss LSM710 confocal with a Zeiss Observer microscope
(SLIM imaging, University of Nottingham).
Transfection of MRC5 lung fibroblasts (2D and 3D culture)
Transfection was performed as described in protocol
provided from lipofectamine 2000® transfection agent.
Briefly, the ratio 1: 2.5 of pNF-κB MetLuc2 reporter (μg)
and transfection agent (μL) was used according to our
optimization result. Firstly, reporter vector and transfection
agent were diluted in 50 μL of Opti-MEM® reduced serum
medium in separate tubes for 20 min at room temperature.
Following which, both diluted reagents were mixed and in-
cubated for 20 min at room temperature and then added
Table 1 Characteristics of PET scaffolds
Concentration of PET Solvent (DCM:TFA) Flow rate (ml/hr) Needle Gauge Voltage (kV) Total Volume (ml) Working Distance
10 % (w/v) 1:1 0.5ml/hr 18G 14kV 2ml 15cm
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100uL dropwise into each well. Before addition, the culture
medium was replaced with 400uL of Opti-MEM®. The cells
were transfected for 5 h in incubators and then refreshed
with complete MEM. In 3D culture, the in situ transfection
method was used in our experiment and the same transfec-
tion procedure was followed as in 2D culture. One positive
control with control vector was kept in both 2D and 3D
experiments to determine transfection efficiency.
Testing dose dependent TNF-α stimulation on NF-κB acti-
vation (2D and 3D culture)
Transfected MRC5 cells in both 2D and 3D culture were
stimulated with 3 concentrations of TNF-α (0.2, 2 & 20 ng/
mL) for 24 h in duplicate wells after 24 h transfection. Cul-
ture medium was refreshed 1 h before the experiment in
order to reduce background reading. Then triplicates of
50 μL supernatants from each well were collected and assay
was performed immediately according to the protocol pro-
vided (or samples were frozen at−20 °C until analysis). A
white 96 well plate was then transferred to a luminometer
(FLUOstar Optima) and analyzed. Data were recorded as
relative light unit (RLU).
Detection cell viability on 2D and 3D culture by Alamar
Blue Assay
Following 24 h incubation with different doses of TNF-
α, viability of MRC5 cells cultured in 2D and 3D was de-
termined by Alamar Blue assay. Cells were incubated
with Alamar blue dye (10 % of the volume of culture
medium) for 4 h at 37 °C with protection from the direct
light. 100uL of triplicate supernatants were transferred
to a 96 black well plate (Fisher Scientific) and read at
λex = 540 nm / λem = 580 nm (FLUOstar Optima)
Data and statistical analysis
Statistical analysis was performed using Graph Prism 6,
San Diego CA. Data are expressed as means ± SEM and
analyzed by one way ANOVA with appropriate post hoc
test for multiple comparisons. Significance level was set
at p < 0.05.
Results and discussion
Development of 3D culture system using non-degradable
Polyethylene terephthalate (PET) electrospun scaffold
For developing the 3D cultures, we electrospun PET
nanofibers (using the parameters summarized in Table 1)
into fiber mats that were used for culturing fibroblasts
in 3D. Scanning electron micrographs of PET scaffold con-
firms the random arrangement of nanofibers with non-
beaded appearance (Figs. 1a and b). Fig. 1c shows average
fibre diameter (257.4 ± 16.28 nm) and pore size (1079 ±
80.74 nm) (mean ± SEM) of 5 independent PET scaffolds.
We have previously shown that these electrospun scaffolds
have comparable geometry to human lung ECM and sup-
port fibroblasts growth and differentiation [32, 33]. There-
fore, in line with our observations, fibroblasts grown on
such scaffold are expected to maintain more in vivo like
morphology, phenotype and functional properties com-
pared to cells grown on 2D substrates .
Detection of TNF-α induced NF-κB activation in lung fi-
broblasts using NF-κB/p65 nuclear translocation
Using fluorescent microscopy, we monitored nuclear
localization of p65 subunit of NF-κB in both 2D and 3D
cultures as a surrogate for NF-κB activation. Figures 2
and 3 show the NF-κB/p65 immunostained images of
MRC5 lung fibroblasts grown on 2D and 3D culture, re-
spectively, after 1 h stimulation with TNF-α (2 ng/mL).
Data clearly show that NF-κB/p65 expression (green)
remained cytoplasmic with almost no nuclear staining in
unstimulated MRC5 cells (Figs. 2 and 3, upper panel)
whereas there was substantial nuclear NF-κB/p65 stain-
ing (Figs. 2 and 3, lower panel) following TNF-α stimula-
tion. DAPI-nuclei labeling (blue) was used to confirm
Fig. 1 Acellular nanofiber PET scaffolds. Representative SEM images of 10 % PET acellular electrospun scaffold dissolved in 1:1 (v/v) DCM: TFA are
shown in different magnifications a (Bar = 10 μm) and b (Bar = 1um). Distributions of fibre diameters and pore sizes of electrospun scaffold are
shown in c (4 random measurements from 5 individual scaffolds) (Mean ± SEM, n = 20)
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the location of nucleus. This finding confirms NF-κB ac-
tivation in lung fibroblasts in response to proinflamma-
tory stimuli TNF-α. Previous in vivo studies in both
human [36–38] and animal models [39–41] have shown
NF-κB activation is associated with a number of inflam-
matory lung diseases (e.g. allergic asthma and chronic
obstructive pulmonary diseases). Taken together, our re-
sults provide evidence for the active involvement of lung
fibroblasts in pulmonary inflammatory responses.
In addition to NF-κB activation, a different morphology
of fibroblasts was observed between 2D and 3D culture
systems. Unlike cells grown in 2D which are aligned next
Fig. 2 TNF-α induced NF-κB Activation in MRC5 lung fibroblasts in 2D culture system. Translocation of NF-κB/p65 was detected in MRC5 fibroblasts
grown in 2D culture system after exposure to TNF-α (2 ng/mL) for 1 h by immunostaining (green color). Nuclei of lung fibroblasts were localized by
DAPI (blue) (a and d). a–c represents cytoplasmic localization of NF-κB/p65 without TNF-α–treatment whereas d–f represents nuclear localization of
NF-κB/p65 in MRC5 with TNF-α treatment for 1 h. The nuclear localization of NF-κB/p65 was overlaid by DAPI nuclear staining (f). (Bar =33 μm, n = 3)
Fig. 3 TNF-α induced NF-κB Activation in MRC5 lung fibroblasts in 3D culture system. Translocation of NF-κB/p65 was detected in MRC5 fibroblasts
grown in 3D culture system after exposure to TNF-α (2 ng/mL) for 1 h by immunostaining (green color). Nuclei of lung fibroblasts were localized by
DAPI (blue) (a and d). a–c represents cytoplasmic localization of NF-κB/p65 without TNF-α–treatment whereas d–f represents nuclear localization of
NF-κB/p65 in MRC5 after TNF-α treatment for 1 h. The nuclear localization of NF-κB/p65 was overlaid by DAPI nuclear staining (f). (Bar =50 μm, n = 3)
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to each other with limited cell-cell contact, fibroblasts
grown in 3D have significantly higher cell-cell interaction
forming networks (Figs. 2 and 3, right panel). There are
also clear differences in the nuclear alignment between
the two systems visualised after DAPI staining (Figs. 2 and
3, left panel) where cells in 2D cultures showed parallel
nuclear alignment compared to a random nuclear ar-
rangement in the 3D culture system. Given the similarities
between the topography of the 3D fibrous scaffolds and
the lung ECM [32, 33, 42, 43], we believe the cellular
orientation observed on 3D scaffolds is likely to be closer
to their arrangement in vivo .
A luciferase reporter assay for real-time and non-invasive
detection of NF-κB activation in lung fibroblasts in 2D
and 3D cultures
Having confirmed the NF-κB activation in lung fibroblasts
by immunostaining, to better quantify such activation we
used a luciferase reporter assay. In this method, NF-κB ac-
tivation was monitored by the amount of luciferase protein
secreted in the culture medium after TNF-α stimulation as
the reporter construct expressing the luciferase gene is
under the control of the NF-κB promoter element.
Firstly both 2D and 3D cultures of fibroblasts were suc-
cessfully transfected with a luciferase reporter vector after
optimization of transfection efficiency with different ratios
of transfection agent to control vector. To ensure parity
between 2D and 3D cultures, we also investigated trans-
fection efficiency between the two culture systems. To this
end, the same number of lung fibroblasts were transfected
with control vector which is designed to express luciferase
protein constitutively without NF-κB promoter element.
This was followed by culturing cells for 24 h in 2D or 3D
before measuring luciferase activity. The 24 hr luciferase
level after transfection was shown to be comparable be-
tween both systems (Fig. 4a).
To investigate the sensitivity of this assay for monitor-
ing NF-κB activation, fibroblasts cultured in 2D and 3D
were stimulated with three concentrations of TNF-α
with 10 fold increments (0.2, 2 and 20 ng/ml) for 24 h
(Fig. 4b). To assess any potential cell death after trans-
fection and post TNF-α stimulation, we also determined
the cell viability after 24 h exposure to different concen-
trations of TNF-α (Fig. 4c). This data showed no signifi-
cant changes in cell viability between 3 concentrations
of TNF-α in both 2D and 3D culture systems. Therefore
any observed differences in NF-κB activation is not due
to changes in cell viability.
As shown in Fig. 4b, all three concentrations of TNF-α
significantly activated NF-κB dependent luciferase pro-
duction in MRC5 fibroblasts compared to unstimulated
control in both 2D and 3D cultures. However, 2D and
3D cultures showed a very different activation pattern
and sensitivity to TNF-α stimulation. Despite the higher
magnitude of NF-κB activation in 2D cultures, cells be-
came non-responsive to TNF-α stimulation in concen-
trations above 2 ng/mL of TNF-α in contrast to 3D
cultures in which cells remained responsive to TNF-α
stimulation even at the highest concentration tested (i.e.
20 ng/mL). The drop in NF-κB activation at higher con-
centrations of TNF-α was not due to reduced cell viabil-
ity in our experiment (Fig. 4c). Such ‘bell-shaped’
pattern of NF-κB activation in 2D cultures is in line with
previous data showing a peak in NF-κB activation in
HEK293 cells in response to 5 ng/mL TNF-α in 2D cul-
tures followed by a drop at higher concentrations [44].
Fig. 4 Detection of NF-κB activation in 2D and 3D cultures by luciferase reporter assay. a Comparison of transfection efficiency between 2D and
3D culture systems. Constitutive luciferase secretion in both systems was measured at 24 hr after transfection with control vector under same ex-
perimental conditions. Data expressed as fold induction over untransfected control value. b Comparison of NF-κB activation between 2D and 3D
culture systems. Transfected MRC5 lung fibroblasts were stimulated with three different doses of TNF-α for 24 h in both systems after transfection.
NF-κB activation was measured as fold induction increment of luciferase reporter activity from respective untreated control. c Assessment of cell viability
between 2D and 3D culture system. Cell viability was assessed by Alamar Blue assay after 24 h stimulation with different doses of TNF-α.
Untreated controls were defined as 100 % and experimental data were expressed as percentage reduction compared to that of control. Data
are mean ± SEM of combined results from three independent experiments and collected as triplicates samples from duplicate wells for each
experiment ****p < 0.0001,**p < 0.01, ns = not significant,(n = 3)
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This effect could be explained by the negative feedback
effect of newly synthesized IκBα at high level of NF-κB
activation. In 2D cultures it has been shown that nuclear
translocation of NF-κB activates the IκBα gene which
has κB binding sites. Thus, the buildup IκBα can inter-
fere with the binding of NF-κB to DNA by binding and
bringing it back to cytoplasm. It can also prevent further
NF-κB uptake by the nucleus [45, 46].
Interestingly, fibroblasts grown in 3D had a dose
dependent response to all TNF-α concentrations albeit the
level of NF-κB activation in 3D cultures was lower than 2D
under the same experimental conditions (Fig. 4b). These
observations are consistent with data from mouse lung tis-
sue showing dose dependent but low level NF-κB activa-
tion in response to TNF-α compared response from liver
tissue where NF-κB activation is at significantly higher
levels but has a narrow dynamic range and drops with in-
creasing concentrations of TNF-α [39]. Overall, these data
suggest fibroblasts cultured in 3D exhibit a more in vivo
like pattern of NF-κB activation in lung which is likely to
be due to differences in TNF receptor expression or differ-
ent regulatory mechanisms involved in controlling NF-κB
activation in 2D versus 3D as a result of differences in cell-
cell contact, cells morphology and polarization.
Together with immunostaining results, these data show
that both detection methods are sensitive enough to de-
tect NF-κB activation in lung fibroblasts cultured in 2D or
3D. However there were significant differences in the acti-
vation pattern and dynamic range of responsiveness to
TNF-α stimulation in 2D and 3D culture systems.
TNF receptor I expression on lung fibroblasts in 2D and
3D cultures
Given that NF-κB activation in response to TNF-α is
dependent on the surface expression of TNF-α receptor,
it was reasonable to assume that the difference in the ei-
ther pattern or level of TNF receptor expression be-
tween the two culture systems could drive difference in
the NF-κB activation levels. Accordingly we examined
the expression of TNF receptor type I (the main TNF re-
ceptor expressed on fibroblasts [47]) in cells cultured in
2D or 3D. Interestingly, receptor expression pattern was
found to be different showing localized expression in 2D
cultures (Figs. 5a and b) which was in contrast with
homogenous expression pattern observed in 3D cultures
(Figs. 5c and d).
As gap junction proteins can be expressed more in cell
populations with higher cell to cell contact [48], we sug-
gest that the formation of cellular networks in 3D culture
system favours the formation of gap junctions between the
fibroblasts. The exchange of molecules including ions and
second messengers via these junctions may link to the
homogenous receptor expression pattern in 3D system as
compared to the focal expression pattern in 2D system
Fig. 5 Immunostaining of TNF receptor I expression of lung fibroblasts in 2D and 3D culture systems. TNF-α receptor I on fibroblast surface was
immunostained with Alexa Fluor® 488 secondary antibody (green) in both 2D (a–b) and 3D (c–d) culture systems and nuclei were labeled with
DAPI (blue). (Bar =50 μm, n = 3)
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[48, 49]. Such differential TNF receptor expression pattern
between 2D and 3D culture systems could at least in part
explain the different dynamics of NF-κB activation be-
tween two culture systems. Stromal cells such as fibro-
blasts naturally grow on 3D extracellular matrix bed that
supports acquiring more physiologically relevant charac-
teristics like receptor expression, proliferation and cyto-
kine production [26]. Fibroblasts grown on 3D porous
scaffolds achieved more complex morphology closer to the
architecture of normal lung tissue [33, 42] and we propose
that the observed NF-κB activation pattern in 3D culture
is more in line with such responses in vivo. This is sup-
ported by studies in animal models showing dose
dependent NF-κB activation in response to LPS challenge
in lung inflammation of transgenic mouse model [39].
Conclusions
In summary, we report the active involvement of lung fi-
broblasts in the context of lung inflammation by activat-
ing NF-κB signaling pathway. Moreover, the 3D culture
system and NF-κB detection methods described in this
study provide a simple but efficient tool for investigating
proinflammatory responses non-invasively and in real-
time under physiologically relevant conditions. To fur-
ther enhance the physiological relevance of this model,
the 3D fibroblast layer and the NF-κB detection system
can be co-cultured with lung epithelial cells as well as
relevant immune cells to create a multi cell immuno-
competent 3D model of human lung. Such a model will
provide a powerful tool for studying cellular and para-
crine cross-talk between lung fibroblasts, immune cells
and other structural cells in the context of acute and
chronic lung inflammation.
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